Regulation of Eosinophil Recruitment and Allergic Airway Inflammation by Tropomyosin Receptor Kinase A
Open Access
- 1 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (3) , 682-693
Abstract
Eosinophilia is a hallmark of allergic airway inflammation (AAI). Identifying key molecules and specific signaling pathways that regulate eosinophilic inflammation is critical for development of novel therapeutics. Tropomycin receptor kinase A (TrkA) is the high-affinity receptor for nerve growth factor. AAI is associated with increased expression of TrkA by eosinophils; however, the functional role of TrkA in regulating eosinophil recruitment and contributing to AAI is poorly understood. This study identifies, to our knowledge, a novel mechanism of eotaxin-mediated activation of TrkA and its role in regulating eosinophil recruitment by using a chemical-genetic approach to specifically inhibit TrkA kinase activity with 1-NM-PP1 in TrkAF592A–knock-in (TrkA-KI) eosinophils. Blockade of TrkA by 1-NM-PP1 enhanced eosinophil spreading on VCAM-1 but inhibited eotaxin-1 (CCL11)–mediated eosinophil migration, calcium flux, cell polarization, and ERK1/2 activation, suggesting that TrkA is an important player in the signaling pathway activated by eotaxin-1 during eosinophil migration. Further, blockade of matrix metalloprotease with BB-94 inhibited eotaxin-1–induced TrkA activation and eosinophil migration, additively with 1-NM-PP1, indicating a role for matrix metalloproteases in TrkA activation. TrkA inhibition in Alternaria alternata–challenged TrkA-KI mice markedly inhibited eosinophilia and attenuated various features of AAI. These findings are indicative of a distinctive eotaxin-mediated TrkA-dependent signaling pathway, which, in addition to other TrkA-activating mediators, contributes to eosinophil recruitment during AAI and suggests that targeting the TrkA signaling pathway to inhibit eosinophil recruitment may serve as a therapeutic strategy for management of eosinophilic inflammation in allergic airway disease, including asthma.Keywords
This publication has 71 references indexed in Scilit:
- NGF – the TrkA to successful pain treatmentJournal of Pain Research, 2012
- Dynamic role of epithelium-derived cytokines in asthmaClinical Immunology, 2012
- Regulation of Eosinophil Trafficking by SWAP-70 and Its Role in Allergic Airway InflammationThe Journal of Immunology, 2012
- Pro-nerve Growth Factor Induces Autocrine Stimulation of Breast Cancer Cell Invasion through Tropomyosin-related Kinase A (TrkA) and Sortilin ProteinJournal of Biological Chemistry, 2012
- Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytesJournal of Biomedical Science, 2011
- Neurotrophins in lung health and diseaseExpert Review of Respiratory Medicine, 2010
- Eosinophils and allergic airway disease: there is more to the storyTrends in Immunology, 2010
- Deficiency of Endothelial Heparan Sulfates Attenuates Allergic Airway InflammationThe Journal of Immunology, 2009
- Mucus hypersecretion in asthma: causes and effectsCurrent Opinion in Pulmonary Medicine, 2009
- trkA Mediates the Nerve Growth Factor-induced Intracellular Calcium AccumulationJournal of Biological Chemistry, 1996